Systemic Lupus Erythematosus (SLE) Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
Systemic Lupus Erythematosus (SLE)Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT07490041
Recruiting
Phase 1
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Systemic Lupus Erythematosus (SLE)Refractory
Chongqing Precision Biotech Co., Ltd12 enrolled2 locationsNCT06892145
Recruiting
Phase 1
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)BlinatumomabChildren
Mao Jianhua6 enrolled2 locationsNCT06789107
Recruiting
Not Applicable
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Bioray Laboratories12 enrolled1 locationNCT05988216